H
Loading...
Loading...
Biologic solutions for chronic wounds include hematogel (autologous), collagen, and CTPs. Pick by wound stage and MAC article. CDC’s 12.0% national diabetes prevalence is the epidemiologic backdrop, not a city-level invention.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18.
Biologic solutions for chronic wounds that won't heal. Advanced therapies including hematogel with 96.5% response rate.
Chronic wounds need etiology, then adjuncts. Collagen, hematogel, amniotic matrix, CTPs — different codes. Pick from the stall and the LCD, not from which flyer arrived this week.
Growth factors and scaffolds are for wounds that have stalled despite standard care — document that stall.
Hematogel’s published response rate is not a CTP meta-analysis and not a city RCT.
Do not stack CTP plus gel plus collagen in one week without a written rationale. It looks like billing, not medicine.
Etiology and LCD — clinician plus coder.
No, but diabetes is a major driver nationally (CDC).
These are clinic-applied products.
Yes, serial — for care and for claims.
Contact us today to learn how Hawk Medical can support your practice.
We're not just a distributor - we're healthcare providers who understand your challenges
We own and operate medical clinics, so we understand your real-world challenges
All products meet strict regulatory requirements including HCT/P 361 compliance
Personal account management and ongoing training for your entire team
10+ years of experience helping practices implement successful programs
Learn more about related treatments, solutions, and resources
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.